Champions Oncology (CSBR) Net Income towards Common Stockholders Growth (1y) (2011 - 2026)
Powered by 
Analysis
Champions Oncology (CSBR) Net Income towards Common Stockholders Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | -9.74% |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 34.46% |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | -29.22% |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | -101.45% |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 96.48% |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 22.54% |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | 8.58% |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | -37.84% |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 8.58% |
| Apr 30, 2026 | 63.65% |
| Jan 31, 2026 | -106.21% |
| Oct 31, 2025 | -67.45% |
| Jul 31, 2025 | -135.49% |
| Apr 30, 2025 | -1,583.49% |
| Jan 31, 2025 | 277.67% |
| Oct 31, 2024 | 135.15% |
| Jul 31, 2024 | 151.17% |
| Apr 30, 2024 | 95.74% |
| Jan 31, 2024 | -3.73% |
| Oct 31, 2023 | -12,843.75% |
| Jul 31, 2023 | -704.39% |
| Apr 30, 2023 | -644.48% |
| Jan 31, 2023 | -409.91% |
| Oct 31, 2022 | -105.78% |
| Jul 31, 2022 | -85.47% |
| Apr 30, 2022 | 48.89% |
| Jan 31, 2022 | -17.94% |
| Oct 31, 2021 | 27,600.00% |